ADC Therapeutics SA (ADCT)
4.04
-0.05
(-1.22%)
USD |
NYSE |
May 17, 12:37
ADC Therapeutics Gross Profit Margin (Quarterly): 86.10% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 86.10% |
December 31, 2023 | 98.49% |
September 30, 2023 | 97.47% |
June 30, 2023 | 93.16% |
March 31, 2023 | |
December 31, 2022 |
Date | Value |
---|---|
September 30, 2022 | 98.30% |
June 30, 2022 | 86.89% |
March 31, 2022 | 98.86% |
December 31, 2021 | 95.47% |
September 30, 2021 | 96.18% |
June 30, 2021 | 96.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
86.10%
Minimum
Mar 2024
98.86%
Maximum
Mar 2022
94.77%
Average
96.48%
Median
Gross Profit Margin (Quarterly) Benchmarks
Roche Holding AG | -- |
Novartis AG | 74.46% |
AC Immune SA | -- |
CRISPR Therapeutics AG | -- |
Addex Therapeutics Ltd | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -53.98% |
Return on Invested Capital | -591.8% |
Profit Margin (Quarterly) | -258.2% |
Operating Margin (Quarterly) | -184.8% |
Return on Net Operating Assets | -345.2% |